You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information. Switch to the US site.

2021

Arjo announces date of 2021 Q3 report and conference call
Arjo Receives Innovative Technology Contract from Vizient for the Provizio[® ]SEM Scanner
Arjo receives 510(k) clearance from US FDA for WoundExpress
Arjo interim report January-June 2021
Research establishes clear health-economic argument for including WoundExpress as standard care in the UK
Arjo announces date of 2021 Q2 report and conference call
Resolutions at Arjo’s Annual General Meeting 27 April 2021
Arjo interim report January-March 2021
Arjo announces date of 2021 Q1 report and conference call
Arjo Annual Report 2020 – Mobility drives improved outcomes in healthcare
Wounds UK publishes consensus around IPC for treating venous leg ulcers – concluding positive results for WoundExpress™
NOTICE OF ANNUAL GENERAL MEETING IN ARJO AB
Arjo publishes year-end report January-December 2020
Arjo announces date of 2020 year-end report and conference call